BG
ELV icon

Baupost Group’s Elevance Health ELV Stock Holding History

Baupost Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$373M Buy
1,275,154
+5,852
+0.5% +$1.92M 7.3% 5
2025
Q4 		$445M Sell
1,269,302
-49,698
-4% -$16.8M 8.43% 4
2025
Q3 		$426M Buy
1,319,000
+703,000
+114% +$219M 8.9% 3
2025
Q2 		$240M Buy
616,000
+370,000
+150% +$149M 5.8% 10
2025
Q1 		$107M Buy
+246,000
New +$98.8M 3.06% 12

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Baupost Group's ELV Position: Q1 2026 in Review

Baupost Group increased its Elevance Health (ELV) stake by 0.46% in Q1 2026, buying an estimated $1.92M and bringing the position to 1,275,154 shares worth $373M. The position accounts for 7.3% of the portfolio, ranked #5.

Baupost Group first reported a position in ELV in Q1 2025 and has held it in 5 quarters since. The position peaked at $445M in Q4 2025. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Baupost Group held 1,275,154 shares of Elevance Health worth $373M as of Q1 2026.
  • Baupost Group bought 5,852 Elevance Health shares in Q1 2026, an estimated $1.92M.
  • Elevance Health made up 7.3% of Baupost Group's portfolio in Q1 2026, its #5 holding.
  • Baupost Group first reported a position in Elevance Health in Q1 2025 and has held it in 5 quarters since.
  • Baupost Group's Elevance Health position peaked at $445M in Q4 2025.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Baupost Group's 13F filing for Q1 2026, filed 14 May 2026.